Medically fit for discharge · patients with perioperative fluid optimization
1 finding from 1 review
Return to pre‐fracture accommodation/return to pre‐fracture mobility · patients with perioperative fluid optimization
1 finding from 1 review
Adverse outcomes ‐ cardiopulmonary · patients with perioperative fluid optimization
1 finding from 1 review
Adverse outcomes ‐ neurological · patients with perioperative fluid optimization
Advanced haemodynamic monitoring showed no clear difference in adverse outcomes ‐ neurological compared with usual care (low certainty).
1 finding from 1 review
Adverse outcomes ‐ all · patients with perioperative fluid optimization
Advanced haemodynamic monitoring showed no clear difference in adverse outcomes ‐ all compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · patients with perioperative fluid optimization
Protocol using standard measures such as CVP showed no clear difference in all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
Length of hospital stay · patients with perioperative fluid optimization
1 finding from 1 review
Medically fit for discharge · patients with perioperative fluid optimization
1 finding from 1 review
Return to pre‐fracture accommodation/return to pre‐fracture mobility · patients with perioperative fluid optimization
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse outcomes ‐ cardiopulmonary · patients with perioperative fluid optimization
1 finding from 1 review
Adverse outcomes ‐ neurological · patients with perioperative fluid optimization
Protocol using standard measures such as CVP showed no clear difference in adverse outcomes ‐ neurological compared with usual care (low certainty).
1 finding from 1 review
Adverse outcomes ‐ all · patients with perioperative fluid optimization
Protocol using standard measures such as CVP showed no clear difference in adverse outcomes ‐ all compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · patients with perioperative fluid optimization
Advanced haemodynamic monitoring showed no clear difference in all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
Length of hospital stay · patients with perioperative fluid optimization
1 finding from 1 review
Relapse, drop‐outs classed as relapse, grouped by length of · patients with maintenance of medically‐induced remission in Crohn's disease
5‐ASA showed no clear difference in relapse, drop‐outs classed as relapse, grouped by length of compared with placebo (moderate certainty).
3 findings from 1 review
RR 0.98 [0.91, 1.07]
11 studies · 2014 participants
Moderate
RR 0.99 [0.8, 1.23]
1 study · 161 participants
Low
RR 1.07 [0.86, 1.33]
1 study · 132 participants
Moderate
Adverse events · patients with maintenance of medically‐induced remission in Crohn's disease
5‐ASA showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with maintenance of medically‐induced remission in Crohn's disease
5‐ASA showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · patients with maintenance of medically‐induced remission in Crohn's disease
5‐ASA showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Duration of diarrhoea · children with acute diarrhoea
The intervention showed no clear difference in duration of diarrhoea (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events (vomiting) · children aged less than 6 months with acute diarrhoea
The intervention probably leads to higher adverse events (vomiting) (moderate certainty).
1 finding from 1 review